September 13th 2025
For patients with MET exon 14-altered NSCLC, Tepmetko was associated with frequent side effects, although the safety profile is considered manageable.
September 11th 2025
September 12th 2025
September 11th 2025
September 10th 2025
September 10th 2025
September 11th 2025
September 10th 2025
September 10th 2025
July 13th 2025